2026 Summer Analyst, Life Sciences Group

Our biopharma banking team provides strategic advice to innovative, cutting-edge companies in the life sciences sector. The rapid and cost-effective development of therapies, products and technologies is critical not just to public health, but to the functioning of society and economic activity. Companies leading the research, development, manufacturing, and commercialization of innovative therapies count on our deep technical and financial expertise to guide their capital-raising and M&A efforts. As industry specialists, our bankers have extensive knowledge of the sector and the competitive landscape, serving clients that are developing therapies, products and technologies across a broad range of therapeutic areas, including oncology, immunology, neurology/CNS, rare disease, genetic medicines, and liver disease, among others.

We know you have choices on how you spend your summer but encourage you to apply for William Blair’s 2026 Biotech Summer Analyst Program. Take the opportunity to build on the fundamentals of your academic background, gain practical knowledge to help prepare you for your next steps and be part of an organization that fosters innovation and invests in our most important asset, our people.